FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2593559094> ?p ?o ?g. }

• W2593559094 endingPage "553" @default.
• W2593559094 startingPage "553" @default.
• W2593559094 abstract "A novel hepatoprotective oleanolic acid derivative, 3-oxours-oleana-9(11), 12-dien-28-oic acid (Oxy-Di-OA), has been reported. In previous studies, we found that Oxy-Di-OA presented the anti-HBV (Hepatitis B Virus) activity (IC50 = 3.13 µg/mL). Remarkably, it is superior to lamivudine in the inhibition of the rebound of the viral replication rate. Furthermore, Oxy-Di-OA showed good performance of anti-HBV activity in vivo. Some studies showed that liver fibrosis may affiliate with HBV gene mutations. In addition, the anti-hepatic fibrosis activity of Oxy-Di-OA has not been studied. Therefore, we evaluated the protective effect of Oxy-Di-OA against carbon tetrachloride (CCl4)-induced liver injury in rats. Daily intraperitoneally administration of Oxy-Di-OA prevented the development of CCl4-induced liver fibrosis, which was evidenced by histological study and immunohistochemical analysis. The entire experimental protocol lasted nine weeks. Oxy-Di-OA significantly suppressed the increases of plasma aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels (p < 0.05). Furthermore, Oxy-Di-OA could prevent expression of transforming growth factor β1 (TGF-β1). It is worth noting that the high-dose group Oxy-Di-OA is superior to bifendate in elevating hepatic function. Compared to the model group, Oxy-Di-OA in the high-dose group and low-dose group can significantly reduce the liver and spleen indices (p < 0.05). The acute toxicity test showed that LD50 and a 95% confidence interval (CIs) value of Oxy-Di-OA were 714.83 mg/kg and 639.73–798.73 mg/kg via intraperitoneal injection in mice, respectively. The LD50 value of Oxy-Di-OA exceeded 2000 mg/kg via gavage in mice. In addition, a simple and rapid high performance liquid chromatography-ultraviolet (HPLC-UV) method was developed and validated to study the pharmacokinetic characteristics of the compound. After single-dose oral administration, time to reach peak concentration of Oxy-Di-OA (Cmax = 8.18 ± 0.66 μg/mL) was 10 ± 2.19 h; the elimination half-life and area under the concentration-time curve from t = 0 to the last time of Oxy-Di-OA was 2.19 h and 90.21 μg·h/mL, respectively." @default.
• W2593559094 created "2017-03-16" @default.
• W2593559094 creator A5015540284 @default.
• W2593559094 creator A5019873683 @default.
• W2593559094 creator A5022055024 @default.
• W2593559094 creator A5022979862 @default.
• W2593559094 creator A5023455267 @default.
• W2593559094 creator A5029599797 @default.
• W2593559094 creator A5029930263 @default.
• W2593559094 creator A5041282060 @default.
• W2593559094 creator A5056291233 @default.
• W2593559094 creator A5057416689 @default.
• W2593559094 creator A5066796969 @default.
• W2593559094 creator A5072243550 @default.
• W2593559094 date "2017-03-06" @default.
• W2593559094 modified "2023-10-05" @default.
• W2593559094 title "A New Oleanolic Acid Derivative against CCl4-Induced Hepatic Fibrosis in Rats" @default.
• W2593559094 cites W1506856062 @default.
• W2593559094 cites W1914843480 @default.
• W2593559094 cites W1963780536 @default.
• W2593559094 cites W1976990630 @default.
• W2593559094 cites W1981900811 @default.
• W2593559094 cites W1983523734 @default.
• W2593559094 cites W1984547449 @default.
• W2593559094 cites W1986551392 @default.
• W2593559094 cites W1986816003 @default.
• W2593559094 cites W1998491055 @default.
• W2593559094 cites W2001596696 @default.
• W2593559094 cites W2004128744 @default.
• W2593559094 cites W2005314332 @default.
• W2593559094 cites W2014047924 @default.
• W2593559094 cites W2015806578 @default.
• W2593559094 cites W2020457566 @default.
• W2593559094 cites W2022687771 @default.
• W2593559094 cites W2025780125 @default.
• W2593559094 cites W2027852061 @default.
• W2593559094 cites W2028911827 @default.
• W2593559094 cites W2032955289 @default.
• W2593559094 cites W2045286805 @default.
• W2593559094 cites W2057723682 @default.
• W2593559094 cites W2061768810 @default.
• W2593559094 cites W2080637212 @default.
• W2593559094 cites W2084622543 @default.
• W2593559094 cites W2091986760 @default.
• W2593559094 cites W2104986283 @default.
• W2593559094 cites W2142988890 @default.
• W2593559094 cites W2170305037 @default.
• W2593559094 cites W2304339487 @default.
• W2593559094 cites W2314160098 @default.
• W2593559094 cites W2314640825 @default.
• W2593559094 cites W58387568 @default.
• W2593559094 cites W73738779 @default.
• W2593559094 cites W2949944330 @default.
• W2593559094 doi "https://doi.org/10.3390/ijms18030553" @default.
• W2593559094 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5372569" @default.
• W2593559094 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28272302" @default.
• W2593559094 hasPublicationYear "2017" @default.
• W2593559094 type Work @default.
• W2593559094 sameAs 2593559094 @default.
• W2593559094 citedByCount "18" @default.
• W2593559094 countsByYear W25935590942018 @default.
• W2593559094 countsByYear W25935590942019 @default.
• W2593559094 countsByYear W25935590942020 @default.
• W2593559094 countsByYear W25935590942022 @default.
• W2593559094 countsByYear W25935590942023 @default.
• W2593559094 crossrefType "journal-article" @default.
• W2593559094 hasAuthorship W2593559094A5015540284 @default.
• W2593559094 hasAuthorship W2593559094A5019873683 @default.
• W2593559094 hasAuthorship W2593559094A5022055024 @default.
• W2593559094 hasAuthorship W2593559094A5022979862 @default.
• W2593559094 hasAuthorship W2593559094A5023455267 @default.
• W2593559094 hasAuthorship W2593559094A5029599797 @default.
• W2593559094 hasAuthorship W2593559094A5029930263 @default.
• W2593559094 hasAuthorship W2593559094A5041282060 @default.
• W2593559094 hasAuthorship W2593559094A5056291233 @default.
• W2593559094 hasAuthorship W2593559094A5057416689 @default.
• W2593559094 hasAuthorship W2593559094A5066796969 @default.
• W2593559094 hasAuthorship W2593559094A5072243550 @default.
• W2593559094 hasBestOaLocation W25935590941 @default.
• W2593559094 hasConcept C102124568 @default.
• W2593559094 hasConcept C126322002 @default.
• W2593559094 hasConcept C142724271 @default.
• W2593559094 hasConcept C150903083 @default.
• W2593559094 hasConcept C178790620 @default.
• W2593559094 hasConcept C185592680 @default.
• W2593559094 hasConcept C203014093 @default.
• W2593559094 hasConcept C204787440 @default.
• W2593559094 hasConcept C207001950 @default.
• W2593559094 hasConcept C2522874641 @default.
• W2593559094 hasConcept C2776637226 @default.
• W2593559094 hasConcept C2777359374 @default.
• W2593559094 hasConcept C2778858181 @default.
• W2593559094 hasConcept C2780559512 @default.
• W2593559094 hasConcept C2780593183 @default.
• W2593559094 hasConcept C29730261 @default.
• W2593559094 hasConcept C2992208098 @default.
• W2593559094 hasConcept C2993667909 @default.
• W2593559094 hasConcept C71924100 @default.

• next